Skip to main navigation Skip to search Skip to main content

Autologous bone-marrow mesenchymal cell induced chondrogenesis (MCIC)

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Degenerative and traumatic articular cartilage defects are common, difficult to treat, and progressive lesions that cause significant morbidity in the general population. There have been multiple approaches to treat such lesions, including arthroscopic debridement, microfracture, multiple drilling, osteochondral transplantation and autologous chondrocyte implantation (ACI) that are currently being used in clinical practice. Autologous bone-marrow mesenchymal cell induced chondrogenesis (MCIC) is a single-staged arthroscopic procedure. This method combines a modified microfracture technique with theapplication of a bone marrow aspirate concentrate (BMAC), hyaluronic acid and fibrin gel to treat articular cartilage defects. We reviewed the current literatures and surgical techniques for mesenchymal cell induced chondrogenesis.
    Original languageEnglish
    Pages (from-to)153-156
    JournalJournal of Clinical Orthopaedics and Trauma
    Volume7
    Issue number3
    DOIs
    Publication statusPublished - 16 Jun 2016

    Keywords

    • Arthrosis
    • Bone marrow aspirate concentrate
    • Cartilage
    • Chondral defect
    • Knee arthroscopy

    Fingerprint

    Dive into the research topics of 'Autologous bone-marrow mesenchymal cell induced chondrogenesis (MCIC)'. Together they form a unique fingerprint.

    Cite this